Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Fung, Kim Y.C.a; * | Priebe, Ilkaa | Purins, Leannea | Tabor, Brucea | Brierley, Gemma V.a | Lockett, Trevora | Nice, Edouardb | Gibbs, Peterc | Tie, Jeanniec | McMurrick, Pauld | Moore, Jamese | Ruszkiewicz, Andrewf | Burgess, Antonyb | Cosgrove, Leah J.a
Affiliations: [a] CSIRO Preventative Health National Research Flagship, Australia | [b] Ludwig Institute for Cancer Research, Melbourne, Australia | [c] Royal Melbourne Hospital, Melbourne, Australia | [d] Cabrini Hospital, Melbourne, Australia | [e] Royal Adelaide Hospital, Adelaide, Australia | [f] SA Pathology, Adelaide, Australia
Correspondence: [*] Corresponding author: Kim Fung, CSIRO Animal, Food and Health Sciences, PO Box 10041, Adelaide BC, South Australia, 5000, Australia. Tel.: +61 8 8303 8840; Fax: +61 8 8303 8899; E-mail: kim.fung@csiro.au.
Abstract: Background:Lipocalin 2 has been implicated in colorectal tumorigenesis but its usefulness as a diagnostic marker for the disease has previously never been determined. Methods:We have used ELISA immunoassay to measure the level of serum lipocalin 2 in a cohort consisting of colorectal cancer patients (n=196) and age/gender matched controls (n=99). Results:The median concentration of lipocalin 2 was found to be significantly higher (p< 0.0001) in the patient group (105.9 ng/mL, range 10.8–444.7 ng/mL) when compared to the control subjects (86.4 ng/mL, range 17.1–190.0 ng/mL). Additionally, no significant difference was observed between disease stage (Dukes’ or T stage) in the patient cohort. Receiver operating characteristic analysis was performed to determine its performance as a diagnostic marker. The area under the curve was found to be 0.641 (95% confidence interval 0.576–0.706). Furthermore, the sensitivity of lipocalin 2 was found to be 24% at 90% specificity. Conclusions:Our study indicates that lipocalin 2 is not a suitable serum biomarker for the diagnosis of CRC.
Keywords: Colorectal cancer, biomarker, blood, diagnosis, lipocalin 2
DOI: 10.3233/CBM-130335
Journal: Cancer Biomarkers, vol. 13, no. 2, pp. 75-79, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl